Cath Lab Recap: Stroke Transport Maps; Fatty Acid-Eluting Stent Interventional cardiology news to note
Centers for Medicare & Medicaid Services finalized its decision to cover leadless pacemakers only in FDA-approved studies. But the agency noted that could include prospective longitudinal studies for on-label use of a device covered by a post-approval study.